Pituitary: Acromegaly and Prolactinoma

OR27-1

The clinical and cardiometabolic effects of D3 growth hormone receptor polymorphism in acromegaly
Nese Cinar, Selcuk Dagdelen, Hikmet Yorgun, Ugur Canpolat, Giray Kabakci and Tomris Erbas

OR27-2

11C-Methionine PET-CT co-registered with volume MRI identifies residual functioning tumour in acromegaly
Olympia Koulouri, Narayanan Kandasamy, Carla M Moran, V Krishna K Chatterjee, David Halsall, Hk Cheow, Nagui Antoun, Andrew Hoole, Neil Burnet, Neil Donnelly, Richard Mannion, John Pickard and Mark Gurnell

OR27-4

EFFECT OF OCTREOTIDE LAR WITHDRAWAL ON CLINICAL, BIOCHEMICAL AND NEURORADIOLOGICAL FINDINGS IN ACROMEGALIC PATIENTS – A PROSPECTIVE STUDY
Lucio Vilar, Luciana Ansaneli Naves, Patricia Sampaio Gadelha, Jose Luciano Albuquerque, Giulliana Nobrega Guimaraes, Christina Cavalcanti Santana, Ana Virginia Gomes, Cyntia Chaves Gomes, Renan Magalhaes Montenegro and Manuel dos Santos Faria

OR27-5

High-dose Cabergoline Treatment of Childhood- and Adolescence-onset Prolactinomas
Nobuhiro Miki, Masami Ono, Yasufumi Seki, Rena Makino and Atsuhiro Ichihara